Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Role of BRAF and RAS Mutations in Extrathyroidal Extension in Papillary Thyroid Cancer.

Cancer genomics & proteomics - 1 Jan 2000

Park Ji Yeon, Yi Jin Wook, Park Chan Hee, Lim Younggyun, Lee Kye Hwa, Lee Kyu Eun, Kim Ju Han

Abstract excerpt

BACKGROUND/AIM: Extrathyroidal extension (ETE) indicates the invasiveness of primary thyroid tumor into the adjacent tissue, and its importance as a prognostic factor overrides tumor size in classifying the cancer stage. The aim of this study was to determine the molecular basis of ETE in papillary thyroid carcinomas (PTCs). MATERIALS AND METHODS: We systematically defined genes and pathways regulated in ETE...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma
Share to Carcinoma, Papillary
Share to Ion Transport

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasm Invasiveness

Share to Thyroid Cancer, Papillary

Share to Thyroid Neoplasms

Share to Tumor Microenvironment

Share to Wnt Signaling Pathway

Source

Identifiers

PMID: 26912807

Genes

BRAF
WNT4
PAX8

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Role of BRAF and RAS Mutations in Extrathyroidal Extension in Papillary Thyroid Cancer.PMID 26912807Read ↗

The BRAFV600E mutation: what is it really orchestrating in thyroid cancer?Semantic proximity Read ↗

High aggressiveness of papillary thyroid cancer: from clinical evidence to regulatory cellular networksSemantic proximity Read ↗

Different Molecular Phenotypes of Progression in BRAF- and RAS-Like Papillary Thyroid Carcinoma.Semantic proximity Read ↗

Overexpression of TPM4 promotes cancer progression through EMT in anaplastic thyroid cancerSemantic proximity Read ↗

Fibronectin Contributes to a BRAF Inhibitor-driven Invasive Phenotype in Thyroid Cancer through EGR1, Which Can Be Blocked by Inhibition of ERK1/2.Semantic proximity Read ↗

BRAFV600E and Microenvironment in Thyroid Cancer: A Functional Link to Drive Cancer ProgressionSemantic proximity Read ↗

E26 transformation (ETS)‑specific related transcription factor‑3 (ELF3) orchestrates a positive feedback loop that constitutively activates the MAPK/Erk pathway to drive thyroid cancerSemantic proximity Read ↗

Transcriptome of Anaplastic Thyroid Cancer Reveals Two Molecular Subtypes with Distinct Tumor Microenvironment and PrognosisSemantic proximity Read ↗

Molecular evaluation of BRAF gene mutation in thyroid tumors: Significant association with papillary tumors and extra thyroidal extension indicating its role as a biomarker of aggressive diseaseSemantic proximity Read ↗

Genome-wide expression analysis suggests a crucial role of dysregulation of matrix metalloproteinases pathway in undifferentiated thyroid carcinomaSemantic proximity Read ↗

The Transcription Factor ETV5 Mediates BRAFV600E-Induced Proliferation and TWIST1 Expression in Papillary Thyroid Cancer CellsSemantic proximity Read ↗

Identification of R-Spondin Gene Signature Predictive of Metastatic Progression in BRAFV600E-Positive Papillary Thyroid Cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.